Sandoz to market authorized generic in the U.S.
Shire’s subsidiary, Shire US Inc.
, has entered an agreement with Sandoz
to supply an authorized generic version of its product Adderall XR. Sandoz will market the authorized generic beginning July 1, 2016. Sandoz has agreed to exclusively sell the authorized generic supplied by Shire from December 1, 2013 through the end of the agreement's five-year term.
Shire will manufacture and supply all dosage strengths of the authorized generic product and Sandoz will distribute the product in the U.S. Shire will receive royalties on sales of the product.